Market Overview

Benzinga's Top Downgrades

Benzinga's Top Downgrades
Related TEVA
Goldman Says These 25 Healthcare Stocks Are Immune To The Election
The Market In 5 Minutes: Industry-Changing M&A In Media, Aerospace, And Financial Services
Healthcare ratings roundup - upgrades/downgrades (Seeking Alpha)
Related RVBD
Riverbed Technology To Deliver Earnings Growth, Experts & Crowd Say
JP Morgan Positive On Brocade Communications' Intent To Acquire SteelApp Assets

Analysts at Canaccord downgraded Teva Pharmaceutical Industries (NYSE: TEVA) from “buy” to “hold.” The target price for Teva has been raised from $50 to $45. Teva's shares closed at $37.96 yesterday.

Analysts at FBR Capital downgraded Riverbed Technology (NASDAQ: RVBD) from “outperform” to “market perform.” The target price for Riverbed has been lowered from $28 to $20. Riverbed's shares closed at $20.10 yesterday.

Analysts at Roth Capital downgraded Skullcandy (NASDAQ: SKUL) from “buy” to “neutral.” The target price for Skullcandy is set to $7. Skullcandy's shares closed at $6.61 yesterday.

CRT Capital downgraded Alpha Natural Resources (NYSE: ANR) from “buy” to “fair value.” The target price for Alpha Natural is set to $8. Alpha Natural's shares closed at $8.51 yesterday.

Latest Ratings for TEVA

Oct 2016MizuhoDowngradesBuyNeutral
Sep 2016OTR GlobalInitiates Coverage onPositive
Sep 2016OppenheimerUpgradesPerformOutperform

View More Analyst Ratings for TEVA
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings


Related Articles (RVBD + ANR)

View Comments and Join the Discussion!